Jean Hubble - Concepedia

Author

Jean Hubble

Also Known As

J Hubble, J P Hubble, J. Hubble, J. P. Hubble, J.P. Hubble, Jean Hubble, Jean P Hubble, Jean P. Hubble, Jean Pintar Hubble

Publications

Citations

H-Index

Concepts

All Affiliations

University of Kansas Medical Center The Ohio State University University of South Florida University of Miami Baylor College of Medicine

About

Jean Hubble is an author at University of Kansas Medical Center specializing in medicine, neurology, and parkinson disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	2.5K
2	Health Sciences	2	2	178
3	Social Sciences	2	2	104
4	Public Health	1	1	39
5	Allergy	1	1	14

Jean Hubble

Publications

6.6K

Citations

H-Index

Page 1

	Year	Citations
Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial Robert G. Holloway, Ira Shoulson, Karl Kieburtz, JAMA Initial TreatmentParkinson DiseaseMedicineNeuropharmacologyPramipexole Vs Levodopa	2000	802
Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease Joelle M. van der Walt, Kristin K. Nicodemus, Eden R. Martin, The American Journal of Human Genetics Mitochondrial BiogenesisMitochondrial FunctionParkinson DiseaseGeneticsGenetic Epidemiology	2003	535
High‐frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor William C. Koller, Rajesh Pahwa, Karen Busenbark, Annals of Neurology	1997	482
Long-term evaluation of deep brain stimulation of the thalamus Rajesh Pahwa, Kelly E. Lyons, Steven B. Wilkinson, Journal of neurosurgery	2006	367
The effect of deprenyl and levodopa on the progression of Parkinson's disease C. Warren Olanow, Robert A. Hauser, L. Gauguster, Annals of Neurology	1995	335
Age at Onset in Two Common Neurodegenerative Diseases Is Genetically Controlled Yi‐Ju Li, William K. Scott, Dale J. Hedges, The American Journal of Human Genetics Neurodegenerative DiseasesAlzheimer's DiseaseAgingDementiaGenetics	2002	312
Randomized trial of the adenosine A <sub>2A</sub> receptor antagonist istradefylline in advanced PD Robert A. Hauser, Jean Hubble, Daniel D. Truong Neurology	2003	296
Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease I Richard, Roger Kurlan, Caroline M. Tanner, Neurology	1997	230
Parkin mutations and susceptibility alleles in late‐onset Parkinson's disease Sofia A. Oliveira, William K. Scott, Eden R. Martin, Annals of Neurology	2003	211
TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial C. Warren Olanow, Anthony H.V. Schapira, Peter A. LeWitt, The Lancet Neurology MedicineParkinson DiseaseNeuropharmacologyNeurochemical BiomarkersNeuroprotection	2006	179

Page 1